Article -> Article Details
Title | Angioplasty Balloons Market Research and Precise Outlook 2019 To 2027 |
---|---|
Category | Fitness Health --> News & Media |
Meta Keywords | Angioplasty Balloons Market |
Owner | vinit |
Description | |
Market Analysis The angioplasty
balloons market is anticipated to touch USD 3457.35 million at
a 5.01% CAGR between 2022- 2027, according to the new report by Market Research
Future (MRFR). Angioplasty is a minimally invasive endovascular technique used
to widen obstructed or narrowed veins or arteries, generally to treat arterial
atherosclerosis. Scoring balloons, drug eluting balloons, cutting balloons, and
normal balloons are the different types of angioplasty balloons that have wide
applications in peripheral artery disease and coronary artery disease. They are
widely used in ambulatory surgical centres, cardiac catheterization
laboratories, hospitals, and others. On the contrary, increasing focus to treat COVID-19 patients
has put cardiac surgeries on halt along with disruption in the supply chain,
thereby limiting the global angioplasty balloons market growth. Regional Analysis Based on the region, the global angioplasty balloons market
report covers the growth opportunities and recent trends across the Americas,
Europe, the Asia Pacific (APAC), the Middle East and Africa (MEA). Of these,
the Americas will dominate the market over the forecast period. The presence of
eminent players, coupled with tie-ups by several companies to expand
geographical footprints, is adding to the global angioplasty balloons market
growth in the region. The global angioplasty balloons market in Europe is
predicted to hold the second-largest share over the forecast period. The
presence of leading industry players and different strategies undertaken by
these players to strengthen their presence, such as mergers and acquisitions
and joint ventures coupled with increased hospitalizations for cerebral
angioplasty and carotid artery angioplasty is adding to the global angioplasty
balloons market growth in the region. The global angioplasty balloons market in the APAC region is
predicted to grow at a fast pace over the forecast period. Manufacturers are
making vigorous marketing activities to increase potential targets which in
turn is adding to the global angioplasty balloons market growth in the
region. The global angioplasty balloons market in the MEA will have
the smallest share over the forecast period but is predicted to grow in the
future for the inclination of top companies to untapped regions. Key Players Key players profiled in the global angioplasty balloons
market report include Endocor (Germany), Cordis (Cardinal Health) (US), Terumo
Medical Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Medtronic
(Ireland), Cook (US), Boston Scientific Corporation (US), C.R. Bard (BD) (US),
Biotronik SE Co. KG (Germany), Abbott (US), and B. Braun Melsungen AG
(Germany). Industry players have incorporated strategies such as mergers,
partnerships, joint ventures, new product launches, and acquisitions to create
a niche in the market. The Western European market has further been classified as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The
European market for angioplasty balloons is expected to hold a substantial
share owing to the increase in the number of cardiac disorder cases. The
angioplasty balloons market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. The
angioplasty balloons market in this region is anticipated to be the
fastest-growing during the forecast period due to the increasing uptake and
adoption rate of newer treatment options by medical professionals. The
increasing patient pool and mortality rate due to cardiac diseases in these
countries also fuel the market growth. For instance, in 2017, ischemic heart
disease was the second-highest cause for death in Japan. The angioplasty
balloons market in the Middle East & Africa has been divided into the
Middle East and Africa. |